The Biotech Growth Trust (LON:BIOG) Releases Earnings Results

The Biotech Growth Trust (LON:BIOG – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX (2.10) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The Biotech Growth Trust had a return on equity of 48.26% and a net margin of 96.47%. The firm had revenue of GBX 10 million for the quarter.

The Biotech Growth Trust Stock Performance

The Biotech Growth Trust stock traded up GBX 16 on Wednesday, reaching GBX 1,354. 37,962 shares of the stock were exchanged, compared to its average volume of 84,182. The stock has a market cap of £247.84 million, a PE ratio of 2.43 and a beta of 0.61. The company has a current ratio of 0.89, a quick ratio of 0.00 and a debt-to-equity ratio of 4.37. The Biotech Growth Trust has a twelve month low of GBX 1,148.60 and a twelve month high of GBX 1,786. The firm has a fifty day moving average price of GBX 1,453.36 and a two-hundred day moving average price of GBX 1,416.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Featured Stories

Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.